Skip to content

Effecten van Mindfulness Based Stress Reduction (MBSR) bij mensen met longkanker.

Effect of Mindfulness Based Stress Reduction on distress, anxiety and depression in patients with lung cancer.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON21858
Enrollment
50
Registered
2013-11-28
Start date
2014-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer - longkanker distress - distress anxiety - angst depression - depressie

Interventions

The intervention, MBSR, is based on the original protocol as described by J. Kabat-Zinn (1990). The group consists of minimal five participants and maximum 15 participants. For eight following weeks p

Sponsors

- Atrium Medisch Centrum - RINO Zuid
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Age > 18 - Diagnosis: lung cancer - ECOG PS max. 2 - Fluent in expression and comprehension of the Dutch language - motivated to complete the MBSR and daily practice at home.

Exclusion criteria

Exclusion criteria: - ECOG PS > 2

Design outcomes

Primary

MeasureTime frame
1. Symptoms of distress, anxiety and depression. Measured with : Distress Thermometer combined with the Problem List ( DT; PL) and the Hospital Anxiety and Depression Scale (HADS).

Secondary

MeasureTime frame
1. Prevalence of fatigue, pain and sleep disturbance. Measured with: Screening Inventory for Psychosocial Problems (SIPP) and weightloss. 2. Copingstyle. Measured with: Mental Adjustment to Cancer scale (MAC-scale) 3. Subjective burden of fatigue, pain and sleep disturbance. Measured with: three items using a seven-point Likert scale. 4. Quality of life (QoL): within the experimental group Q0L will be measured using the Dutch version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) including the specific module for Lung Cancer (QLQ-LC13)

Contacts

Public ContactI. Lux,

Wijngracht 45 Postbus 640 6460 AP Kerkrade

i.lux@atriummc.nl045 576 6490

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)